Pituitary site of action of endothelin: selective inhibition of prolactin release in vitro.
Endothelin-3 (ET-3) inhibited in a dose-dependent, significant fashion prolactin release from cultured anterior pituitary cells (ovariectomized female and intact male rat donors, ED50 = 5 X 10(-9) M). ET-3 in log doses ranging from 10(-11) to 10(-6) M did not alter significantly the release of luteinizing hormone, growth hormone or thyroid stimulating hormone. The inhibitory effect of ET-3 (rat, human) was specific for that molecule since ET-1 (porcine, human) was ineffective and was not due to an action on the dopamine receptor since the inhibitory action was still expressed in the presence of 100 nM domperidone. These data further suggest a role for neuropeptides of the posterior lobe in the control of lactotroph function.
Samson
W K
WK
Department of Anatomy and Neurobiology, University of Missouri, School of Medicine, Columbia 65212.
Skala
K D
KD
Alexander
B D
BD
Huang
F L
FL
D000818:Animals; D002478:Cells, Cultured; D004294:Domperidone / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D016232:Endothelins; D004730:Endothelium, Vascular; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D010052:Ovariectomy; D010455:Peptides / Q000494:pharmacology*; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D012016:Reference Values; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D016232:Endothelins; D010455:Peptides; D004294:Domperidone; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D004298:Dopamine